Kast A, Hermer M
Corporate Division of Non-Clinical Drug Safety, Boehringer Ingelheim KG, Fed. Rep. of Germany.
J Perinat Med. 1993;21(2):97-106. doi: 10.1515/jpme.1993.21.2.97.
A literature of 92 scientific papers addressing the effects of beta-adrenoceptor stimulation on the heart have been collected with the support of a computer-based MEDLINE system and critically examined. Neither in animal experiments nor in a wide clinical use of tocolytics for more than two decades has a risk for the hearts of fetus and neonate been confirmed, because there is no or only very little stimulating action on the beta-adrenoceptors of fetal and newborn's hearts as their sympathetic innervation is still immature.
在基于计算机的医学文献数据库MEDLINE系统的支持下,我们收集了92篇关于β - 肾上腺素能受体刺激对心脏影响的科学论文,并进行了严格审查。在动物实验以及超过二十年的广泛临床使用宫缩抑制剂的过程中,均未证实对胎儿和新生儿心脏存在风险,因为对胎儿和新生儿心脏的β - 肾上腺素能受体没有或仅有非常微弱的刺激作用,因为他们的交感神经支配仍不成熟。